Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
When do you consider systemic therapy for patients with progressive fibrosing mediastinitis?
Related Questions
What is your approach to evaluating amiodarone induced interstitial pneumonitis?
What is your approach to counseling and managing patients with LAM desiring pregnancy?
What factors would encourage you to choose abatacept vs tocilizumab in a patient with RA-ILD with a UIP pattern of pulmonary fibrosis?
What is your approach to treatment in a patient with radiographic UIP but pathologic evidence of both fibrotic NSIP and UIP?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
Do you utilize cytokine panels to guide treatment of patients with EGPA?
Do you routinely integrate telomere length testing into the evaluation of patients with ILD?
How frequently do you monitor CT scans, PFTs, and TTEs in patients with ILA or mild ILD?
What is the duration of steroids that you prescribe for organizing pneumonia?
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
